CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Palliative cancer care - nausea & vomiting - Management
What issues do I need to be aware of before prescribing cyclizine?
- Cyclizine can be given two to three times a day by mouth or subcutaneous or intravenous injection; or by continuous subcutaneous infusion. Subcutaneous administration may cause skin irritation at the injection site.
- Drowsiness and antimuscarinic adverse effects (dry mouth and blurred vision) are common.
[Twycross and Wilcock, 2001]
© NHS Institute for Innovation and Improvement